Showing results (1421-1430 of 2,116) with videos related to
Sort By:
Pageof 212
Helicobacter|June 19, 2010
Cost-effectiveness of endoscopic surveillance for gastric intestinal metaplasiaCesare Hassan, Angelo Zullo, Emilio Di Giulio, et al.Helicobacter|July 17, 2010
Role of mucin Lewis status in resistance to Helicobacter pylori infection in pediatric patientsSara Lindén, Cristina Semino-Mora, Hui Liu, et al.Helicobacter|April 21, 2010
Type I restriction-modification loci reveal high allelic diversity in clinical Helicobacter pylori isolatesSönke Andres, Anna Skoglund, Christina Nilsson, et al.Helicobacter|April 21, 2010
Comparison of the efficacy of the two tetracycline-containing sequential therapy regimens for the eradication of Helicobacter pylori: 5 days versus 14 days amoxicillinZüleyha A Cetinkaya, Mesut Sezikli, Fatih Güzelbulut, et al.Helicobacter|April 21, 2010
Ten-day sequential therapy as first-line treatment for Helicobacter pylori infection in Korea: a retrospective studyJung H Kwon, Dong H Lee, Byeong J Song, et al.Helicobacter|March 3, 2009
Reduction of Helicobacter infection in IL-10-/- mice is dependent on CD4+ T cells but not on mast cellsDominique Velin, Daniel Bachmann, Hanifa Bouzourene, et al.Helicobacter|March 21, 2009
Comparison of a stool antigen test and serology for the diagnosis of Helicobacter pylori infection in mass surveyTadashi Shimoyama, Takao Oyama, Masashi Matsuzaka, et al.Helicobacter|March 21, 2009
Impact of quadruple regimen of clarithromycin added to metronidazole-containing triple therapy against Helicobacter pylori infection following clarithromycin-containing triple-therapy failureNobue Ueki, Kazumasa Miyake, Masafumi Kusunoki, et al.Helicobacter|March 21, 2009
A randomized clinical trial to determine the efficacy of regimens containing clarithromycin, metronidazole, and amoxicillin among histologic subgroups for Helicobacter pylori eradication in a developing countryLori Ann Fischbach, Luis Eduardo Bravo, Guillermo Rosero Zarama, et al.Helicobacter|March 21, 2009
Meta-analysis: four-drug, three-antibiotic, non-bismuth-containing "concomitant therapy" versus triple therapy for Helicobacter pylori eradicationAbdallah Said Essa, Jennifer Rosenthal Kramer, David Y Graham, et al.Pageof 212